Search

Your search keyword '"Elena Henkel"' showing total 57 results

Search Constraints

Start Over You searched for: Author "Elena Henkel" Remove constraint Author: "Elena Henkel"
57 results on '"Elena Henkel"'

Search Results

1. Sudomotor Testing of Diabetes Polyneuropathy

2. CRISPR/Cas9-mediated knockout of c-REL in HeLa cells results in profound defects of the cell cycle.

3. Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers

4. Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial

5. Hypoglycemia is associated with acute changes in the QTc interval and reduced heart rate in type 2 diabetic patients with cardiovascular disease in a real world setting

6. 133-OR: Effects of Empagliflozin on Liver Fat Content in Type 2 Diabetes: The EMLIFA001 Trial

7. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

8. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

9. Efficacy and safety of once-Weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): A 56-Week, open-Label, randomized clinical trial

10. IKK1/2 protect human cells from TNF-mediated RIPK1-dependent apoptosis in an NF-κB-independent manner

11. Physical Activity is Strongly Inversely Related To Post-Challenge Plasma Glucose and Glycemic Spikes in a Risk Population for Type 2 Diabetes

13. The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial

14. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus

15. Acarbose Slows Progression of Intima-Media Thickness of the Carotid Arteries in Subjects With Impaired Glucose Tolerance

16. Insulin Secretion and Insulin Sensitivity Pattern Is Different in Isolated Impaired Glucose Tolerance and Impaired Fasting Glucose

17. Coagulation factor V G allele and HR2 haplotype

18. Leukocyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population for diabetes

19. Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes

20. Prädiktoren von Glukosetoleranzstörungen in einer Risikopopulation für Typ-2-Diabetes: die RIAD-Studie

22. Correlation between VEGF-A, biomarker of inflammation and dysglycemia

23. Intima-Media-Dicke bei Gesunden ohne Risikofaktorenfür Arteriosklerose

24. Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study

25. Impaired fasting glucose is not a risk factor for atherosclerosis

26. Serum and Plasma Levels of Vascular Endothelial Growth Factors in Relation to Quality of Glucose Control, Biomarkers of Inflammation, and Diabetic Nephropathy

27. Efficacy and Safety of Once-Weekly Semaglutide vs. Exenatide ER after 56 Weeks in Subjects with Type 2 Diabetes (SUSTAIN 3)

28. Association of physical activity with insulin resistance, subclinical inflammation, coagulation, and fibrinolytic biomarkers among population at high risk for type 2 diabetes

31. Pulse pressure is a strong predictor of cardiovascular risk: Data of the risk factors in impaired glucose tolerance for atherosclerosis and diabetes and the Sofia Metabolic Syndrome studies

33. Untersuchung zur retinalen Gefäßfunktion bei gut eingestellten Typ-2-Diabetikern mittels dynamischer retinaler Gefäßanalyse

34. Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis

40. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

41. Adiponectin und Leptin: postprandialer Verlauf und die Beziehungen zu den Parametern der Insulin-Glukose-Homöostase in verschiedenen Glukosetoleranzstadien

42. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study

43. Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals

44. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals

46. Impaired glucose tolerance is not associated with lipidintolerance

49. Is the newly suggested fasting plasma glucose cut-off point for the diagnosis of diabetes the right one?

50. Observations

Catalog

Books, media, physical & digital resources